• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. Cancer Immunotherapy

Cancer Immunotherapy

A woman in an Allcyte lab coat looking at images of cancer cells on a screen.
Tech

British A.I. drug discovery startup Exscientia buys Austrian cancer cell screening company

By Jeremy Kahn
June 15, 2021
Photo of CytoSeek CEO Carolyn Porter
Tech

New venture fund backs CytoSeek, a startup looking to give “superpowers” to cancer-fighting T-cells

By Jeremy Kahn
March 16, 2021
Photo of U.S. Speaker of the House Nancy Pelosi wearing a mask and gesturing with her hands.
Health

A Pelosi snub and a giant federal COVID grant: Another dizzying day in Washington for the U.K.’s AstraZeneca

By Jeremy Kahn
October 12, 2020
A sign is seen at an AstraZeneca site in Macclesfield
Health

Here’s Why Shares in This Former Pfizer Target Are Tanking

By Fortune Editors and Reuters
July 27, 2017
Going to the Wall Against Cancer and Apathy: FDR, Obama, Trump, Laver, and Kyrgios
Commentary

Going to the Wall Against Cancer and Apathy: FDR, Obama, Trump, Laver, and Kyrgios

By Paul Sanderson and Bethany Cianciolo
July 13, 2017
Inside The Nasdaq MarketSite As Juno Therapeutics Releases IPO
Health

Why Shares of Next-Gen Cancer Biotech Juno Rallied Today

By Sy Mukherjee
July 14, 2016
Stocks Continue Downward Slide On Heels Of Yesterday's Extreme Fall
Health

This Fund Wants to Make It Easier to Invest in Biotech Stocks

By Sy Mukherjee
June 15, 2016
Bristol Myers Yervoy Cancer Drug
Health

FDA Has Strong Words for Cancer Drug Developers

By Reuters
June 10, 2016
The Powerful And Influential Attend Clinton Global Initiative Annual Meeting
Health

Merck CEO: We’re on the Hunt for Deals in 2016

By Sy Mukherjee
May 6, 2016
Napster co-founder, Sean Parker, General
Health

Sean Parker Launches an Unprecedented Cancer Research Effort

By Laura Lorenzetti
April 13, 2016

Most Popular

  • Success
    Healthcare is the one profession growing right now—and according to OpenAI CEO Sam Altman, it may be the only one...
    By Jessica Coacci
  • Economy
    Congressional Budget Office says Trump's immigration crackdown will shrink U.S. population faster than expected, a...
    By Sasha Rogelberg
  • Commentary
    My wife sold her engagement ring to pay our tax bill. It led to my PhD and my career tackling the student-debt crisis
    By Brian Walsh
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.